India significantly strengthened its position as a global pharmaceutical and medical technology hub in 2025, with major achievements across affordable healthcare, domestic manufacturing, research innovation, and global collaboration. The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, reported record investments, exports, and innovation milestones during the year. Janaushadhi…
Tag: #IndianPharma
Defence Atmanirbharta: Record Production & Rising Exports
India recorded a record ₹1.54 lakh crore in defence production in FY 2024–25 while defence exports surged to ₹23,622 crore milestones that underline the success of sustained policy reforms, expanding private-sector participation and a growing defence manufacturing ecosystem dominated by thousands of MSMEs. Numbers that mark a turning point Indigenous…
CCI Approves Torrent Pharma–JB Chemicals Deal
The Competition Commission of India (CCI) has granted approval for Torrent Pharmaceuticals Ltd to acquire J. B. Chemicals & Pharmaceuticals Ltd, subject to voluntary modifications offered by both companies. This clearance paves the way for a major consolidation in India’s pharmaceutical industry, with the proposed deal involving share acquisition and subsequent…
India Develops Nafithromycin: Boost to Self-Reliant Healthcare
New Delhi, 19 October 2025 – India has achieved a major milestone in medical research with the development of its first indigenously discovered antibiotic, Nafithromycin. Effective against resistant respiratory infections, it is particularly beneficial for cancer patients and individuals with poorly controlled diabetes. The antibiotic is the first molecule conceptualized,…
